Delivery Order SPE2DB22D1106-SPE2DB24FFFL2
Award Date
8/5/24
Potential Completion Date
8/6/24
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office division is a $2,152.42 Firm Fixed Price Delivery Order for the supply of FLUTICASONE PROP HFA 220 MCG 12GM pharmaceutical products. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 11, 2024. This contract is not designated as a set-aside and serves as a delivery vehicle for Amerisourcebergen to provide a range of essential...
This federal contract award is a delivery order valued at $1,994.73, issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,565,259,713 units of the pharmaceutical product Fluticasone Prop HFA 110 MCG 12GM. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,571.49 for the supply of Fluticasone Prop HFA 110 MCG 12GM. The award was made by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of August 9, 2024. The contract is a Firm Fixed Price arrangement. Amerisourcebergen is supplying this pharmaceutical product as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Medical Supply Chain unit of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,726.26 firm fixed price delivery order is for the provision of 4,564,909,174 units of the pharmaceutical product Fluticasone Prop HFA 220 MCG 12GM. The contract has an ultimate completion date of June 17, 2024. Amerisourcebergen, a major supplier of pharmaceuticals and medical supplies to the federal government, holds a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The $3,728.88 firm fixed price delivery order has a performance period through March 15, 2024. Amerisourcebergen Drug Corp previously received an indefinite delivery contract (IDC) from DLA, valued up to $999,999,999.00 through December 31, 2025, to provide a...
This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen), a major pharmaceutical distributor, is for the delivery of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,947.32 firm fixed-price delivery order contract has a completion date of November 21, 2023. Amerisourcebergen is the prime contractor, and the contract is not designated with a set-aside. The company also holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,187.36 firm fixed-price delivery order is for the supply of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product. The contract has an ultimate completion date of March 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, valued at $2,681.73, is for the delivery of the pharmaceutical product Fluticasone Prop HFA 220 MCG 12GM. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 3, 2024. This award is not associated with a set-aside program. Amerisourcebergen is a major supplier of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is a delivery order valued at $1,307.59 for the supply of the pharmaceutical product fluticasone prop HFA 44 mcg 10.6 gm. The award was made by the Defense Logistics Agency (DLA), a defense agency, with a period of performance through July 2024. The contract is for firm fixed-price delivery of this pharmaceutical item and does not have a set-aside designation. Amerisourcebergen is a major supplier of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $6,378.92 firm-fixed-price delivery order is for the supply of Fluticasone Propionate HFA 44 mcg, a pharmaceutical product. The contract has a completion date of September 10, 2024. AmerisourceBergen is a major supplier of pharmaceutical and medical products to the federal government, and this award is part of the company's extensive Indefinite...